Antibodies against oxidized phospholipids in laboratory tests exploring lupus anti-coagulant activity.

作者: R. Rolla , M. Vidali , R. Serino , P. Pergolini , E. Albano

DOI: 10.1111/J.1365-2249.2007.03404.X

关键词:

摘要: Lupus anti-coagulants (LA) are a variety of anti-phospholipid antibodies characterized by their capacity to interfere with phospholipid-dependent coagulation assays. LA increasingly recognized as important predictors thrombosis. However, the antigen specificity is still poorly characterized. Growing evidence indicates that oxidized phospholipids among targets antibodies. This prompted us investigate role IgG directed against different in 164 subjects without clotting factor defects were tested for presence using LA-sensitive activate partial thromboplastin time (aPTT-FSL) and screening/confirmation assay based on diluted Russell's viper venom test (dRVVT-PL). The response aPTT-FSL was significantly (P < 0.0005) associated high titres phosphatidylserine, phosphatidylethanolamine phosphatidylinositol, whereas positivity dRVVT-PL elevation phosphatidylcholine, phosphatidylinositol 0.01). No difference reactivity cardiolipin evident between groups. Positivity also 0.005) anti-cardiolipin anti-beta(2)-glycoprotein-1 IgG. stepwise logistic regression demonstrated recognizing phosphatidylcholine only independent assay, while test. In conclusion, autoantibodies defined detection or assays might contribute variability often observed responses functional tests detecting LA.

参考文章(33)
Graham Rv Hughes, Munther A Khamashta, Maria Laura Bertolaccini, Revisiting antiphospholipid antibodies: from targeting phospholipids to phospholipid binding proteins. Clinical Laboratory. ,vol. 50, pp. 653- 665 ,(2004)
C. ZOGHLAMI-RINTELEN, R. VORMITTAG, T. SAILER, S. LEHR, P. QUEHENBERGER, H. RUMPOLD, C. MALE, I. PABINGER, The presence of IgG antibodies against β2‐glycoprotein I predicts the risk of thrombosis in patients with the lupus anticoagulant Journal of Thrombosis and Haemostasis. ,vol. 3, pp. 1160- 1165 ,(2005) , 10.1111/J.1538-7836.2005.01394.X
Clive Kearon, Epidemiology of Venous Thromboembolism Seminars in Vascular Medicine. ,vol. 01, pp. 007- 026 ,(2001) , 10.1055/S-2001-14668
Freda H. Passam, Steven A. Krilis, Laboratory tests for the antiphospholipid syndrome: current concepts. Pathology. ,vol. 36, pp. 129- 138 ,(2004) , 10.1080/00313020410001671966
K Veres, G Lakos, A Kerényi, Z Szekanecz, G Szegedi, Y Shoenfeld, P Soltész, Antiphospholipid antibodies in acute coronary syndrome Lupus. ,vol. 13, pp. 423- 427 ,(2004) , 10.1191/0961203304LU1011OA
O. VAARALA, M. PUURUNEN, M. LUKKA, G. ALFTHAN, M. LEIRISALO-REPO, K. AHO, T. PALOSUO, Affinity-purified cardiolipin-binding antibodies show heterogeneity in their binding to oxidized low-density lipoprotein Clinical and Experimental Immunology. ,vol. 104, pp. 269- 274 ,(1996) , 10.1046/J.1365-2249.1996.21728.X
Tatsuya Atsumi, Masahiro Ieko, Maria L. Bertolaccini, Kenji Ichikawa, Akito Tsutsumi, Eiji Matsuura, Takao Koike, Association of autoantibodies against the phosphatidylserine-prothrombin complex with manifestations of the antiphospholipid syndrome and with the presence of lupus anticoagulant. Arthritis & Rheumatism. ,vol. 43, pp. 1982- 1993 ,(2000) , 10.1002/1529-0131(200009)43:9<1982::AID-ANR9>3.0.CO;2-2
Ronald H.W.M. Derksen, Philip G. de Groot, Tests for lupus anticoagulant revisited. Thrombosis Research. ,vol. 114, pp. 521- 526 ,(2004) , 10.1016/J.THROMRES.2004.06.009
H Takeya, T Mori, E C Gabazza, K Kuroda, H Deguchi, E Matsuura, K Ichikawa, T Koike, K Suzuki, Anti-beta2-glycoprotein I (beta2GPI) monoclonal antibodies with lupus anticoagulant-like activity enhance the beta2GPI binding to phospholipids. Journal of Clinical Investigation. ,vol. 99, pp. 2260- 2268 ,(1997) , 10.1172/JCI119401